Effect of two surfactants on in vitro permeation of butorphanol through horse nasal mucosa

Keywords: butorphanol, development of intranasal formulation, equines, intranasal


The aim of the present study was to evaluate the effect of two surfactants on in vitro permeation of butorphanol through equine nasal mucosa. Franz diffusion cells and equine nasal mucosa were used. Three formulations were developed based on citric acid, sodium citrate, sodium chloride, and butorphanol tartrate and administered at a 24.4 g cm-3 dose. Control formulation lacked any penetration enhancer. Formulation 1 (F1) had a cationic surfactant (cetrimonium bromide) and formulation 2 (F2) had a non-ionic surfactant (Tween 80). Statistically comparing flux values at the steady state (Jss), apparent permeability coefficient (Kp), and lag-time from control, F1 and F2 for the respiratory region does not show statistically significant differences (α= 0.05). However, statistically significant differences were found on the Jss and Kp, values from control, F1, and F2 in olfactory mucosa. A statistical analysis on the latter showed significant differences between the Jss values of F1 and F2 and between control and F2. Based on this, Tween 80 proved to be a promising excipient in developing intranasal butorphanol formulations in equines since it increases its passage through the nasal mucosa. These results are very promising to continue with the development of intranasal butorphanol formulation in equines.


Cárdenas, L. N. (2016). Diseño de soluciones químicas para la extracción de ácido desoxirribonucleico en productos biotecnológicos. UGCiencia, 22(1), 37-44. https://doi.org/10.18634/ugcj.22v.1i.553
Dale, O., Hjortkjaer, R., & Kharasch, E. D. (2002). Nasal administration of opioids for pain management in adults. Acta anaesthesiologica scandinavica, 46(7), 759-770. https://doi.org/10.1034/j.1399-6576.2002.460702.x
Ferreira, V., Teme Centurion, O., & Landoni, M.F. (2015). Evaluación de la vía intranasal para la administración de opioides en equinos. Invet, 17, 63–64.
Ferreira, V., Velloso, M. I., & Landoni, M. F. (2019). Bioavailability of butorphanol after intranasal administration to horses. Bulgarian Journal of Veterinary Medicine. http://tru.uni-sz.bg/bjvm/bjvm-2019-0051%20OnFirst.pdf
Franz, T. (1978). The finite dose technique as a valid in vitro model for the study of percutaneous absorption. Current Problems in Dermatology, 7, 58–68. https://doi.org/10.1159/000401276
Gao, M., Mei, D., Huo, Y., & Mao, S. (2019). Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats. Drug delivery and translational research, 9(1), 311-318. https://doi.org/10.1007/s13346-018-0580-y
Grassin-Delyle, S., Buenestado, A., Naline, E., Faisy, C., Blouquit-Laye, S., Couderc, L. J., Guen, M. L., Fischler, M. & Devillier, P. (2012). Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacology & therapeutics, 134(3), 366-379. https://doi.org/10.1016/j.pharmthera.2012.03.003
Haq, A., M., Chandler, M., & Michniak-Kohn, B. (2020). Solubility-physicochemical-thermodynamic theory of penetration enhancer mechanism of action. International Journal of Pharmaceutics, 575, 118920. https://doi.org/10.1016/j.ijpharm.2019.118920
Jim, E., Riviere, J. E., & Papich, M. G. (2009). Veterinary Pharmacology and Therapeutics. New York, United States.
Kaur, G., & Mehta, S. K. (2017). Developments of Polysorbate (Tween) based microemulsions: Preclinical drug delivery, toxicity and antimicrobial applications. International journal of pharmaceutics, 529(1-2), 134-160. https://doi.org/10.1016/j.ijpharm.2017.06.059
Matthews, N. S., & Carroll, G. L. (2007). Review of equine analgesics and pain management. Proceedings of the Annual Convention of the American Association of Equine Practitioners (pp. 240-244). Orlando, Florida.
Prabhakar, K., Afzal, S. M., Surender, G., & Kishan, V. (2013). Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharmaceutica Sinica B, 3(5), 345-353. https://doi.org/10.1016/j.apsb.2013.08.001
Som, I., Bhatia, K., & Yasir, M. (2012). Status of surfactants as penetration enhancers in transdermal drug delivery. Journal of pharmacy & bioallied sciences, 4(1). https://doi.org/10.4103/0975-7406.92724
Tadros, T. (2014). Colloid and interface aspects of pharmaceutical science. H. Ohshima & K. Makino (Eds.), Colloid and Interface Science in Pharmaceutical Research and Development. Oxford, UK, Elsevier, 29-54. https://doi.org/10.1016/B978-0-444-62614-1.00002-8
Talevi, A. & Bellera, C. L. (2016). Absorción de fármacos. A. Talevi, P. Quiroga, & M. E. Ruiz (Coords.), Procesos biofarmacéuticos (pp. 25-38). Editorial de la Universidad de La Plata. https://doi.org/10.35537/10915/51907
Thorat, S. (2016). Formulation and Product Development of Nasal Spray: An Overview. Scholars Journal of Applied Medical Sciences, 4(8D), 2976-2985.
Velloso, M. I., Ferreira, V., Vita, M., & Landoni, M. F. (2019). Vía intranasal: Una alternativa para la administración de fármacos de acción central en equinos. Analecta Veterinaria, 39(1), 033. https://doi.org/10.24215/15142590e033
Velloso, M. I., Andreeta, A., & Landoni, M. F. (2018). Puesta a punto un método espectrofotométrico UV/Vis en microplaca para la cuantificación de butorfanol en exposición oral. En VIII Jornadas de Jóvenes Investigadores, 2018. Facultad de Ciencias Veterinarias, Universidad Nacional de Buenos Aires.
Vetter, A., Augustijns, P., & Bernkop-Schnürch, A. (2012). Solubilizing agents in nasal formulations and their effect on ciliary beat frequency. Toxicology in Vitro, 26(1), 150-156. https://doi.org/10.1016/j.tiv.2011.10.011
How to Cite
Velloso, M., Andreeta, H., & Landoni, M. (2021). Effect of two surfactants on in vitro permeation of butorphanol through horse nasal mucosa. Uniciencia, 35(2), 1-9. https://doi.org/10.15359/ru.35-2.1
Original scientific papers (evaluated by academic peers)

Comentarios (ver términos de uso)